P2 Survey TELL US WHAT YOU WANT TO KNOW!

Through our sister site, Physicians Practice, we are able to provide you with news and information you can use to help run your private medical practice from experts covering everything from health IT innovations to small rewards for your office staff. But now we want to hear from our other experts - you. Take our brief editorial survey to tell us what you want to read in the coming year both in print and online. We've provided some topics, you just tell us how interested you are in these ideas. By completing the survey, you'll have the chance to enter to win a $500 Visa gift card. The survey will run through July 27th. No purchase is necessary. Void where prohibited. Visa is not a particular in or sponsor of this Sweepstakes. See official rules for full details.

 

TELL US WHAT YOU WANT TO KNOW!


Through our sister site, Physicians Practice, we are able to provide you with news and information you can use to help run your private medical practice from experts covering everything from health IT innovations to small rewards for your office staff.

But now we want to hear from our other experts - you.

Take our brief editorial survey to tell us what you want to read in the coming year both in print and online. We've provided some topics, you just tell us how interested you are in these ideas.

By completing the survey, you'll have the chance to enter to win a $500 Visa gift card.

The survey will run through July 27th. No purchase is necessary. Void where prohibited. Visa is not a particular in or sponsor of this Sweepstakes. See official rules for full details.

 

Related Videos
Noa Biran, MD, an expert on multiple myeloma
Experts on multiple myeloma
Experts on GVHD with a patient
Experts on GVHD with a patient
An expert from Dana-Farber Cancer Institute discusses findings from the final overall survival analysis of the phase 3 ENGOT-OV16/NOVA trial.
The use of palliative care in ovarian cancer resulted in a decrease in overall readmissions and index hospitalization costs.
Current clinical trials look to assess 177Lu-PSMA-617 in combination with other therapies including androgen deprivation therapy and docetaxel.
An expert from Dana-Farber Cancer Institute indicates that patients with prostate cancer who have 1 risk factor should undergo salvage radiotherapy following radical prostatectomy before their prostate-specific antigen level rises above 0.25 ng/ml.
Experts on RCC
Related Content